Skip to main content

EU-Belarus-Russia Network in Nanomaterials-Driven Anti-Cancer Gene Therapy

Objective

Dendrimers are a new class of nanomaterials. They are monodisperse, stable, and are characterized by relatively low viscosity at high molecular mass and numerous end groups that can be ionized, which means that they can efficiently bind a large amount of genetic material and deliver it to ill organs and tissues (gene therapy). The partners of project from EU countries organized European research network in the field of dendrimers. They collaborate in the frames of EU Framework 7 Programme supported grants and initiatives: COST, MNT ERA NET 2007, ERA NET EuroNanoMed 2010. Belarus and Russia partners started to collaborate in the field of multifunctional dendrimer/carbon nanotubes as gene carriers on the basis of bilateral collaboration grant. Present project is devoted to combining of these two independent networks in one EU-Belarus-Russia platform in the field of nanomaterials for biomedical applications. The main objective of NANOGENE project is to provide the tight collaboration of six institutions from European Union, Russia and Belarus in the field of nanomaterials-driven delivery of anti-cancer siRNA into cancer cells. The aims to be achieved are: I: Encouragement and promotion of the international collaboration (trainings, promoting and facilitating the international collaboration relevant to FP8); II: International networking and strengthening of the research collaboration (workshops, strengthening the research management and scientific links existing among participating university/academia partners and distribution of best practice in FP8 project administration); III: scientific results realized in the number of papers in peer-reviewed journals and presentation of joint results at conferences. Such international co-operation is important for building linkages between EU countries and Belarus and Russia for creating better relations between institutions which results in more united Europe and for future joint FP8 proposals.

Field of science

  • /medical and health sciences/medical biotechnology/genetic engineering/gene therapy
  • /medical and health sciences/clinical medicine/oncology/cancer
  • /engineering and technology/nanotechnology/nano-materials

Call for proposal

FP7-PEOPLE-2012-IRSES
See other projects for this call

Funding Scheme

MC-IRSES - International research staff exchange scheme (IRSES)

Coordinator

UNIWERSYTET LODZKI
Address
Ul Prezydenta Gabriela Narutowicza 68
90 136 Lodz
Poland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 193 800
Administrative Contact
Maria Jolanta Bryszewska (Prof.)

Participants (3)

UNIVERSIDAD DE ALCALA
Spain
EU contribution
€ 89 300
Address
Plaza De San Diego
28801 Alcala De Henares/madrid
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Rafael Gómez Ramírez (Dr.)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
EU contribution
€ 91 200
Address
Rue Michel Ange 3
75794 Paris
Activity type
Research Organisations
Administrative Contact
Patrick Mounaud (Mr.)
SERVICIO MADRILENO DE SALUD
Spain
EU contribution
€ 13 300
Address
Plaza Carlos Trias Bertran 7
28020 Madrid
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Administrative Contact
Maria-ángeles Muñoz-Fernández (Prof.)